Your browser doesn't support javascript.
loading
CREB5 reprograms FOXA1 nuclear interactions to promote resistance to androgen receptor-targeting therapies.
Hwang, Justin H; Arafeh, Rand; Seo, Ji-Heui; Baca, Sylvan C; Ludwig, Megan; Arnoff, Taylor E; Sawyer, Lydia; Richter, Camden; Tape, Sydney; Bergom, Hannah E; McSweeney, Sean; Rennhack, Jonathan P; Klingenberg, Sarah A; Cheung, Alexander T M; Kwon, Jason; So, Jonathan; Kregel, Steven; Van Allen, Eliezer M; Drake, Justin M; Freedman, Matthew L; Hahn, William C.
Afiliación
  • Hwang JH; Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, United States.
  • Arafeh R; Department of Medicine, University of Minnesota, Minneapolis, United States.
  • Seo JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States.
  • Baca SC; Broad Institute of MIT and Harvard, Cambridge, Cambridge, United States.
  • Ludwig M; Harvard Medical School, Boston, United States.
  • Arnoff TE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States.
  • Sawyer L; Broad Institute of MIT and Harvard, Cambridge, Cambridge, United States.
  • Richter C; Harvard Medical School, Boston, United States.
  • Tape S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States.
  • Bergom HE; Broad Institute of MIT and Harvard, Cambridge, Cambridge, United States.
  • McSweeney S; Harvard Medical School, Boston, United States.
  • Rennhack JP; Department of Pharmacology, University of Minnesota-Twin Cities, Minneapolis, United States.
  • Klingenberg SA; Warren Alpert Medical School of Brown University, Providence, United States.
  • Cheung ATM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States.
  • Kwon J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States.
  • So J; Broad Institute of MIT and Harvard, Cambridge, Cambridge, United States.
  • Kregel S; Harvard Medical School, Boston, United States.
  • Van Allen EM; Department of Medicine, University of Minnesota, Minneapolis, United States.
  • Drake JM; Department of Medicine, University of Minnesota, Minneapolis, United States.
  • Freedman ML; Department of Medicine, University of Minnesota, Minneapolis, United States.
  • Hahn WC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States.
Elife ; 112022 05 12.
Article en En | MEDLINE | ID: mdl-35550030
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores Androgénicos / Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Prognostic_studies Límite: Humans / Male Idioma: En Revista: Elife Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores Androgénicos / Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Prognostic_studies Límite: Humans / Male Idioma: En Revista: Elife Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido